In conclusion, afatinib induced apoptosis in NSCLC cell lines without EGFR mutation through a novel mechanism, the Elk-1/CIP2A/PP2A/p-AKT pathway. This evidence concerns the gene CIP2A and non-small cell lung carcinoma.